dydrogesterone has been researched along with Adverse Drug Event in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergeron, C; Ferenczy, A; Pornel, B; Quereux, C | 1 |
1 other study(ies) available for dydrogesterone and Adverse Drug Event
Article | Year |
---|---|
Continuous combined hormone replacement therapy with 1 mg 17beta-oestradiol and 5 mg dydrogesterone (Femoston-conti): endometrial safety and bleeding profile.
Topics: Aged; Cross-Sectional Studies; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Dydrogesterone; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Postmenopause; Treatment Outcome; Uterine Hemorrhage | 2006 |